Male birth control pill moves closer to reality
NCT ID NCT01382069
First seen Nov 20, 2025 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tested a new pill called dimethandrolone undecanoate (DMAU) as a possible male contraceptive. In two parts, healthy men aged 18 to 50 received either a single dose or daily doses for 28 days to check safety and how the drug works in the body. The goal is to develop a safe, effective daily birth control pill for men.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Los Angeles Biomedical Research Institute
Torrance, California, 90502, United States
-
University of Washington
Seattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.